Stocks›Healthcare›BLFS

BLFS

BioLife Solutions, Inc.

NasdaqResearch view

Healthcare · Electromedical & Electrotherapeutic Apparatus · Small-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$1.8B

Enterprise Value$1.7B

Income$-4.6M

Sales$96.2M

Book/sh$7.60

Cash/sh$0.68

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio4.63

Current Ratio5.94

Debt/Eq0.03

EPS (ttm)$-0.10

EPS this Y77.3%

EPS past 3/5Y—

Sales past 3/5Y8.1%

EPS Y/Y TTM77.3%

Sales Y/Y TTM28.9%

Shs Outstand48.91M

ROA-1.1%

ROE-1.2%

ROIC-4.8%

Gross Margin64.6%

Oper. Margin-17.3%

Profit Margin-4.8%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$119.2M

2021

$76.2M

2022

$68.0M

2023

$74.6M

2024

$96.2M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$119.2M	$76.2M	$68.0M	$74.6M	$96.2M
Gross Profit	—	—	$41.3M	$50.1M	$62.1M
Operating Income	$-35.2M	$-5.9M	$-17.2M	$-4.5M	$-16.6M
Net Income	$-8.9M	$-139.8M	$-68.0M	$-20.2M	$-4.6M
Diluted EPS	$-0.23	$-3.25	$-1.55	$-0.44	$-0.10
Operating Cash Flow	$-4.6M	$-8.5M	$-12.5M	$8.4M	$20.1M
Free Cash Flow	$-13.0M	$-18.9M	$-18.9M	$5.2M	$10.6M